抗EGFR（Cetuximab）嵌合抗體 | Anti-EGFR (Cetuximab), Chimeric Antibody貨號A1047-100
| 代理廠牌： |  |
| 原廠連結： | |
| 相關下載： |
抗EGFR（西妥昔單抗）嵌合抗體 | 貨號A1047-100
Anti-EGFR (Cetuximab), Chimeric Antibody
BioVision的研究級生物仿製藥。基於人IgG的單克隆抗體（mAb）是癌症治療中增長最快的類別。 幾種單克隆抗體已被FDA批准用於治療各種solid tumors實體瘤和hematological malignancies血液惡性腫瘤。 BioVision提供人IgG型式之的research grade biosimilars 研究級生物仿製藥以供應研究需求。 單克隆抗體使用具有來自治療性抗體的可變區的重組技術製造，以實現相似的安全性和功效。 這些抗體可用作臨床前鑑定之對照和用於開發新型治療劑之效力測定。主要特徵：無添加劑：在含有防腐劑的PBS緩衝液（0.02％Proclin 300）; 高純度：使用蛋白A> 98％純度; 多功能：可用於各種應用; ELISA，Neutralization，流式細胞術，IHC，IF
Immunofluorescent and Immunohistochemical staining using anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody (Cat. No. A1096-200) (A & B) and Anti-CD52 (Campath-1H), Human IgG1 Antibody (Cat. No. A1105-200) (C & D).
Cetuximab產品介紹: Anti-EGFR (Cetuximab)西妥昔單抗是重組人/小鼠嵌合表皮生長因子受體（EGFR）單克隆抗體。 表皮生長因子受體（EGFR）是在正常細胞和腫瘤細胞上發現的對細胞生長重要的受體。 Cetuximab西妥昔單抗是一種EGFR抑制劑，用於通過阻斷EGFR的活性並防止癌症生長而治療癌症。 Cetuximab西妥昔單抗可以通過與腫瘤細胞上的EGFR結合而形成觸發免疫反應的橋樑。 它用於治療表達EGFR的轉移性結腸直腸癌。
更多抗體 抗CD20（利妥昔單抗） | 抗α5β1整合素（Volociximab） | Anti-HER2 (Trastuzumab) | 抗VEGF（Bevacizumab） | 抗EGFR（西妥昔單抗）嵌合抗體 | 抗CD11a（Efalizumab)） | Anti-PD-L1 (Atezolizumab)
| Cat # +Size | A1047-100 |
| Size | 100 µg |
| Antibody Target | EGFR |
| Alternate Name | Erbitux |
| Host | Human/Mouse chimeric |
| Antibody Type | Monoclonal |
| Isotype | Human IgG1 |
| Immunogen | Human A431 cells |
| Accession # | AAI18666 |
| Gene ID | 1956 |
| Appearance | Colourless liquid |
| Formulation | In Phosphate buffered saline, pH 7.4. |
| Purification | IgG purified from murine cell culture supernatant by protein A chromatography |
| Species Reactivity | Human |
| Application | Neutralization, ELISA |
| Application & Usage | Neutralization : 1-20 μg/ml; ELISA: 2μg/ml |
| Cat. No. | Product Name | Trade Name | Isotype | Size |
| A1045-100 | Anti-VEGF (Bevacizumab), humanized Antibody | Avastin | Human IgG1 | 100 µg |
| A1046-100 | Anti-HER2 (Trastuzumab), humanized Antibody | Herceptin | Human IgG1 | 100 µg |
| A1047-100 | Anti-EGFR (Cetuximab), Chimeric Antibody | Erbitux | Human IgG1 | 100 µg |
| A1048-100 | Anti-TNF-α (Adalimumab), humanized Antibody | Humira | Human IgG1 | 100 µg |
| A1049-100 | Anti-CD20 (Rituximab), Chimeric Antibody | Mabthera | Human IgG1 | 100 µg |
| A1050-100 | Anti-EGFR (Panitumumab), humanized Antibody | Vectibix | Human IgG1 | 100 µg |
| A1088-200 | Anti-OX40L (Oxelumab), Human IgG1 Antibody | Xolair | Human IgG1 | 200 µg |
| A1089-200 | Anti-CD11a (Efalizumab), Human IgG1 Antibody | Raptiva | Human IgG1 | 200 µg |
| A1090-200 | Anti-EGFR (Matuzumab), Human IgG1 Antibody | Matuzumab | Human IgG1 | 200 µg |
| A1091-200 | Anti-CD4 (Clenoliximab), Human IgG4 Antibody | Clenoliximab | Human IgG4 | 200 µg |
| A1092-200 | Anti-alpha 5 beta 1 Integrin (Volociximab), Human IgG4 Antibody | Volociximab | Human IgG4 | 200 µg |
| A1093-200 | Anti-TNF alpha (Humicade), Human IgG4 Antibody | Humicade | Human IgG4 | 200 µg |
| A1094-200 | Anti-CD40L (Ruplizumab), Human IgG1 Antibody | Antova | Human IgG1 | 200 µg |
| A1096-200 | Anti-Carcinoembryonic antigen (Arcitumomab), Human IgG1 Antibody | CEA-Scan | Human IgG1 | 200 µg |
| A1097-200 | Anti-TNF alpha (Infliximab), Human IgG1 Antibody | Remicade | Human IgG1 | 200 µg |
| A1098-200 | Anti-IL-2R alpha (CD25) (Basiliximab), Human IgG1 Antibody | Simulect | Human IgG1 | 200 µg |
| A1099-200 | Anti-IL-2R alpha (Daclizumab), Human IgG1 Antibody | Zenapax | Human IgG1 | 200 µg |
| A1105-200 | Anti-CD52 (Campath-1H), Human IgG1 Antibody | Campath | Human IgG1 | 200 µg |
| A1305-100 | Anti-PD-L1 (Atezolizumab), Humanized Antibody | Tecentriq | Human IgG1 | 100 µg |
| A1306-100 | Anti-PD-1 (Pembrolizumab), Humanized Antibody | Keytruda | Human IgG1 | 100 µg |
| A1307-100 | Anti-PD-1 (Nivolumab), Humanized Antibody | Opdivo | Human IgG1 | 100 µg |
蛋白質定量商品 Coomassie blue蛋白質定量分析套組 | BCA蛋白測定試劑盒(低濃度10-600ug/ml)| 5％耐洗滌 | BCA蛋白測定試劑盒 (還原劑兼容)